The role of nitric oxide in bacillus Calmette-Guerin mediated anti-tumour effects in human bladder cancer
1998

The Role of Nitric Oxide in BCG Treatment for Bladder Cancer

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): OT Jansson, E Morcos, L Brundin, JON Lundberg, J Adolfsson, M Söderhill, NP Wiklund

Primary Institution: Karolinska Hospital

Hypothesis

Is nitric oxide involved in the anti-tumour activity of bacillus Calmette-Guerin (BCG) in bladder cancer treatment?

Conclusion

Nitric oxide production is significantly increased in the bladder following BCG treatment, suggesting it plays a key role in the anti-tumour effects of this therapy.

Supporting Evidence

  • Patients treated with BCG showed a 30 times higher production of nitric oxide in the bladder.
  • Calcium-dependent nitric oxide synthase activity increased fourfold in BCG-treated patients compared to normal controls.
  • NO donors exhibited cytotoxic effects on bladder cancer cell lines.

Takeaway

This study found that a substance called nitric oxide increases a lot when patients receive BCG treatment for bladder cancer, which might help fight the cancer.

Methodology

The study involved measuring nitric oxide synthase activity and nitric oxide production in bladder tissue from patients treated with BCG.

Limitations

The study had a small sample size and did not assess the long-term effects of nitric oxide on cancer progression.

Participant Demographics

Patients included 8 treated with BCG for recurrent superficial bladder cancer and 12 with recurrent papillary bladder cancer.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication